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Summary
The mechanism behind natural tumor resistance conveyed by a H-21)d transgene to C57B1/6
(B6) mice was investigated . Transgenic D8 mice were more efficient than control mice in natural
killer (NK) cell mediated rapid elimination of intravenously inoculated radiolabeled lymphoma
cells ofB6 origin, such asRBD5 . There was no differencebetweenD8 andB6 micewhen elimination
ofYAC-1 targets was monitored. The effect of the transgene on the NK repertoire was related
to the H-2 phenotype of the target : the differential elimination ofRBDS lymphoma cells in
D8 and B6 mice was not seen when a H-2 deficient variant of this line was used (efficiently
eliminated in both genotypes), nor was it seen with a H-21)d transfectant (surviving in both
genotypes) . The data show that a MHC class I transgene can directly control natural killing
in vivo by altering the repertoire rather than the general levels of NK activity. Since theNK
mediated elimination seen after introduction of a novel gene in the host was neutralized by
introducing the same gene (H-2Dd), but not an unrelated class I gene (H-2Dp), in the tumor,
the data support the concept of NK surveillance against missing self . This combined
traitsgenic/transfectant system may serve as a tool for a molecular dissection of the interactions
between NK cells and their targets in vivo .
S
everal steps in immune responses are controlled by genes
of theMHC . MHC class I and II genes educate, tolerize
or activate the T cell subsets (1-5) . There is also evidence
for aMHC influence on NK cell function . Ft-hybrid resis-
tance mediated by natural killer cells against tumor and bone
marrow grafts is one example (6-9) . This phenomenon is
poorly understood in comparison with the detailed knowl-
edge ofhow MHC genes control the T cell system (1-5) .
It is not clear whether the genetic control of natural immu-
nity involves the classicalMHC genes, but natural resistance
against lymphoma grafts has been mapped close to MHC
class I genes in linkage studies (8, 9) . We have reported that a
H-2Dd transgene introduced in C57B1/6 (B6) 1 mice convey
natural resistance to lymphoma grafts ofB6 origin (10) . This
resistance was dependent on the presence of NK cells, since
it was abrogated by treatment of transgenic mice with mAbs
against NK1.1 or heteroantiserum against asialo-GMI (10) .
The purpose of the present study was to investigate two aspects
of this rejection . First, does the H-2Dd transgene directly
influence rapidNK mediated elimination, or is the transgene
effect indirect, i.e., does it recruit NK cells as effectors in a
1 Abbreviations used in this paper . B6, C57B1/6; 1251-IUdR, 5'-[ 125111odo-2'-
deoxyuridine.
later stage of a rejection response. Second, if the transgene
affects natural killing directly, does it control the general levels
ofNK activity or the specificity pattern in their "repertoire",
i.e., killing of some but not all targets? In particular, is the
H-2 phenotype of the target important?
We have studied these questions by following the early
events after inoculation ofradiolabeledlymphomacells in trans-
genic and control mice. The clearance of 5'-[t251]Iodo-2'-
deoxyuridine (125I_IUdR) labeled cells has previously been
used to measure NK activity in vivo (11-14) . One advantage
of this rapid assay is that it allows in vivo tests of natural
resistancewithout the interference ofthe slowerT cell medi-
ated reactions against allogeneic or strongly immunogeneic
tumors . Our results show that introduction of the H-2Dd
geneonB6 background affects early NK mediated elimina-
tion against some, but not all targets. Furthermore, theH-2
phenotype of the target appears to be crucial for the trans-
gene effect, as shown most clearly in experiments with H-2
mutant and transfected subclones of the RBD5 lymphoma .
Materials and Methods
Mice.
￿
Mice were bred and maintained at the Department of
Tumor Biology, Karolinska Institutet. B6 mice were also purchased
fromALAB (Sollentuna, Sweden) . The generation ofthe transgenic
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fragment from the plasmid pDdl (16) containing theH-2D' gene
wasmicroinjected into fertilized B6 embryosand reimplanted into
pseudopregnant B6 females. The expression and tissue distribution
of the H-2D' gene paralleled that of the endogenous Kb and Db
genes (17, 18). TheDS strain wasakind gift from Dr. Gilbert Jay.
Tumors.
￿
H-26 tumors : RMA is a subline of the T cell lym-
phoma RBL5 . RMA-S is a H-2 deficient variant ofRMA, gener-
ated by repeated cycles of negative selection using mouse allo anti-
H-2b antisera and complement (19, 20) . RMAS has a defect in
the association between the class I heavy chains and (3Z-micro-
globulin (/3z m), resulting in a decreased expression of H-2 on the
cell surface (21) . RBL-5pDd1 and RBL-5DP are RBL-5 sublines
transfected with the plasmids pDd1 (16) and pRM15 (22), respec-
tively . EL-4 is a benzpyrene induced, andALC a RAD-LV in-
duced T cell lymphoma . H-2° tumors: YAC-1 is aT cell lymphoma
inducedby Moloney Leukemia Virus in the A/Sn strain .A.H-2-
is a ,fl2m deficient variant of YAC-1 with no detectable cell sur-
face expression of class I antigens (21, 23) . H-2d tumors : L1210 is
aT cell lymphoma and P815 is a mastocytoma, both inducedby
benzpyrene in theDBA/2 strain . All tumors were maintained as
ascites lines in the syngeneic strain and explanted to in vitro cul-
ture 1-4wk before experiments were carried out . Table 1 lists the
different cell lines used in this study.
In Vivo Rapid Elimination Assay .
￿
Tumor cells (106/ml) were in-
cubated over night in the presence of 0.5 P.Ci/ml of 5'-[ 12'I]Iodo-
2'-deoxyuridine ("5I-IUdR ; Amersham, Sweden AB, Solna,
Sweden). Before inoculation, the radiolabeled cells were washed
3-4 times with large volumes of PBS and adjusted to 5 x 106/ml
in PBS . The activity of the inoculation volume (106 cells in 200
pl) was determined and was usually in the range of 2-4 x 105
cpm . At different timepoints after inoculation, the mice were killed
andthe lungs, livers, and spleens removed . The remaining radioac-
tivity in each organ was measured in a gamma counter and ex-
pressed as percentage of the total activity inoculated .
Pretreatment of Mice with Anti-NK1.1 Antibody.
￿
One day be-
fore inoculation of tumor cells, themice were givenone single in-
jection of200 Al ascites prepared anti-NK1 .1 mAb(24) . This treat-
' Weak but detectable expression .
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ment has previously been shown to abrogate natural killer cell
activity in vivo (25) .
Transfection .
￿
RBL5 cells were electroporated together with the
plasmidpDd1, encoding the Dd gene (16), or pRM15, coding for
the DP gene (22), in a BIO-RAD genepulser (BIO-RAD, Rich-
mond, California). Electroporation was carried out in0.4 ml PBS
at 250 Voltsand960microFahrads. After 10 min at room tempera-
ture the cells were put in RPMI with 10% FCS (normal culture
conditions) . When the number of surviving cells were 5-10 x
106, the dead and live cells were separated using Ficoll/hypaque
(Pharmacia, Uppsala, Sweden) centrifugation, and subsequently
sorted on a Fluorescence Activated Cell Sorter (FACS®4; Becton
Dickinson and Co ., San Jose, California) . In the case of DP,
cotransfection with the neomycin resistance gene wasperformed,
and before sorting, a G418 resistant population was selected to en-
rich for clones expressing the class I gene. Cells were labeled with
H-2D' specific (34-4-8S, reference 26) or H-2DP specific (7-16.10,
reference 27)mAband positive cells were sorted on theFACS. After
4-5 such rounds of selection, stable transfectants were obtained
that expressed H-2D1 or H-2DP in addition to the endogenous
H-2b molecules. The resulting transfectants, RBL5pDd1 and
RBL5DP were sensitive to H-2Dd and H-2DP specific CTL respec-
tively, and they were both sensitive to H-2b specific allo CTL
(not shown) .
Indirect Immunofluorescence. 106 tumor cells were incubated
with 100 P,1 of hybridoma supernatant 30-60 min on ice, washed
with PBS, and incubated with 100 jA1FITC conjugated rabbit anti-
mouse Ig (Dakopatts, Hagersten, Sweden) . After washing, the cells
were analyzed on the FACS .
Statistical Analysis.
￿
Statistical calculations were performed using
a two-tailed, non-paired t test . In cases where the variances be-
tweenthegroups were not comparable, theCochran t test was used .
Results
Survival of H-26 Lymphomas after Intravenous Inoculation to
B6 and H-2Dd Transgenic Mice. Radiolabeled lymphoma
Table 1. Cell Lines Used in this Study
MHC
H-2'
class I
H-2b
haplotype
H-2d Transfected gene
Tumor cell Parental tumor Strain Inducing agent (KkDd) (KbDb) (KdD') (D
d
) (DP)
RBL-5 - C57B1/6 Rancher virus
RMA RBL-5 C57B1/6 Raucher virus
RMA-S RBL-5 C57B1/6 Raucher virus (+)" - - -
RBL-5pDd1 RBL-5 C57B1/6 Raucher virus
RBL-5DP RBL-5 C57B1/6 Raucher virus
EL-4 - C57B1/6 Benzpyrene
ALC - C57B1/6 RAD-LV
YAC-1 - A/Sn Moloney virus
A.H-2- YAC-1 A/Sn Moloney virus
P815 - DBA/2 Methylcholantrene
L1210 - DBA/2 MethylcholantreneEL-4 ALC
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Figure 1 .
￿
Elimination ofRBL5 (A) and ofEL4 andALC (B) in C57B1/6
(B6) and D8 mice. The remaining radioactivity in the different organs
indicates the amount of surviving cells, and is expressed as a percentage
ofthe total amount radioactivity inoculated. In both experiments the mice
were killed 12 h after tumor cell inoculation . In (B), only lung values
are shown . All figures in this paper show arithmetic mean and SE from
at least four mice in each group, unless anything else is indicated. The
differences between B6 andD8 in (A) were statistically significant in the
lung (p < 0.01) and in the liver (p< 0.05) but not in the spleen . In (B),
the differences between B6 and D8 were significant
￿
< 0.001) for both
EL4 and ALC . Data for D8 in (A) is mean value
￿
om three mice .
cells were inoculated into B6 and D8 mice. Survival of inoc-
ulated cells was estimated by measuring remaining radioac-
tivity in different organs at different time points . There was
a significant difference in pulmonary clearance ofRBI,51ym-
phoma cells between control B6 and transgenic D8 mice at
12 h after inoculation . The same pattern was seen in the liver,
while there was a marginal difference in the spleen (Fig. 1
A) . The terms clearance or elimination will be used for this
difference in endpoint survival of lymphoma cells, since ki-
netic studies (further discussed below) showed that there was
no difference in homing patterns oflymphoma cells in the
different genotypes of mice. To study whether this differ-
ential elimination was a general phenomenon or unique to
RBLS, we inoculated two other lymphomas with high
H-2b expression, ALC and EL4 . The same selective elimi-
nation in the D8 mice was seen also for these lymphomas
(Fig . 1 B) .
Target Cell Specificity ofthe Transgene Eject.
￿
In contrast
to the H-2b lymphomas, YAC-1 cells were eliminated equal-
ly efficiently in B6 and D8 mice at 12 h (Fig. 2 A) . YAC-1
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￿
Elimination of YAC-1 in B6 and D8 mice after 12 h (A) and
in B6, D8, CBA, and A/Sn after 3 h (B) . Data in (A) is obtained from
the same experiments as in Fig. 1A . In (B), only lung values are shown .
The difference between A/Sn andCBA in (B) were statistically significant
(p < 0.05) .
is known to be efficiently killed by NK cells within hours
in vitro as well as in vivo (14) . It was possible that the 12-h
time point was suboptimal to detect a H-2Dd mediated
difference in clearance, but we failed to observe any differ-
ence in survival in assays after 3 h (Fig. 2 B) . The previously
known genetic differences inNK activity between A/Sn (low),
B6 (intermediate) and CBA (high) (14) were readily detect-
able at this time point .
The 1,1210 lymphoma and P815 mastocytoma, both of
DBA/2 (H-2d) origin, gave the same pattern as YAC-1 .
They were equally well eliminated inD8 and B6 mice, whether
tested after 3 (P815, Fig. 3 A), 12 (P815, Fig. 3 B) or 21
(1,1210, Fig. 3 C) h . RMA (Fig. 3 B) or RBL5 (Fig . 3 C)
were included as a control for transgene induced elimination .
Expression of H-21)d was a common feature for the three
tumors for which there was no difference in elimination be-
tween control and transgenic mice . To test whether the lack
of transgene effect on clearance of YAC-1 cells was depen-
dent on the H-2Dd product (or class I expression in general)
at the tumor cell level, we inoculated cells from the YAC-1
variant line A.H-2 - . This line does not express any class I
gene products at the cell surface due to a translational block
of the 92m mRNA (21, 22) . Nevertheless, this cell was
equally well eliminated from D8 and B6 mice (Fig. 4) . The
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￿
Remaining radioactivity in the lungs of ofB6 and DS mice
for P815 (A), RMA and P815 (B) and RBIr5 and L1210 (C) . For each
experiment, thedifferent timepoints are indicated inparentheses . Data for
RMA to D8 in (B) was obtained from three mice. The differences between
B6 and D8 for RMA (p < 0.01 in Fig. 3 B) and RBL5 (p < 0.001 in
Fig. 3 C) were statistically significant .
differences in general levels ofNK activity between A/Sn and
CBA (14) were detected for this cell line also (Fig. 4) .
Survival ofRBLS in Transgenic and Normal B6 Mice, Role
ofNK1 .1 Positive Cells and Lymphoma Class IExpression .
￿
An-
other property that distinguishes the B6 lymphomas from
YAC-1, P815 and L1210 is that only the former expresses
H-2b . To test whether the transgene induced difference in
clearance was dependent on H-2KbDb expression in RBIr5,
we inoculated the class I low variant lineWA-S . There was
no difference between B6 and (D8 x B6)Ft mice for this
variant, which has a95% reduction in H-2b expression com-
pared to RBIr5 (19, 20) . It was efficiently cleared from the
lungs in both genotypes (Fig. 5) .
The difference between (D8 x B6)Fi and B6 mice in
lung clearance ofRBIr5 cells was abrogated by pretreatment
of hosts with anti-NK1.1 mAb (Fig . 5) . This treatment also
greatly reduced the difference in clearance between RB1r5
and H-2 deficient RMAS cells in B6 hosts .
The NK mediated elimination of normal RBIr5 cells in
Figure 4 .
￿
Elimination of H-2 negative YAC-1 variant A.H-2- . The
figure shows remaining radioactivity in the lungs of B6, D8, CBA and
A/Snmice 3 h afterinoculation. Mean oftwo experiments . Thedifference
between A/Sn and CBA was significantly different (p < 0.01) .
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￿
Effect of anti-NK1 .1 treatment on 12-h survival ofRMA and
H-2 deficient variant RMA-S in the lungs of B6 and (D8 x B6)Fl mice .
In this experiment all data for B6 and data forRMA-S in untreated (D8
x B6)Ft were obtained from groups of three mice . The difference be-
tween B6 and (D8 x B6)Fj for RMA was statistically significant (p <
0.001) .
D8 or (D8 x B6)Fi mice and of syngeneic but H-2
deficient RBL5 cells (RMAS) in B6 mice suggested that
self match with respect to H-2 phenotype prevented natural
killing (Fig. 5, references 19, 20) . The effect of the transgene
would then be a consequence of a redefinition of "self' in
the transgenic mice, creating a situation ofincomplete match
to the H-2b lymphomas. This predicted that the difference
in elimination oftheselymphomas between D8 andB6 mice
should disappear if the H-21)d gene was introduced in the
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￿
Remaining radioactivity (after 12 h) ofnormal, H-2Dd trans-
fected RBIr5 or H-2DP transfected RBD5 in the lungs of B6 and D8
mice. The figure is a summaryoftwo independent experiments. Thenumber
of mice in each host/tumor combination was 8 except for R31. 5 to B6
where 9 mice were used. The difference between B6 andD8 was statisti-
cally significant for RBI65 (p < 0.05) and RBL5DP (p < 0.01), but not
for RBL5pDd1 . Just before the experiments, the transfected cells were
analyzed for the expressionof thetransfectedgenes, as describedin materials
and methods. Fluorescencevalues (lin) from a representative analysis were
for Kb, Db, Dd, DP and no antibody respectively : RBL5 (353, 453, 24,
12, 13), RBIT5pDd1 (267, 312, 217, n .d ., 15) and RBIr5DP (310, 370,
n .d ., 147, 11) . n .d ., a not determined.
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- NK1 .1lymphoma; it shouldnow survive in both hosts . To test this,
the RBD5 lymphoma was transfected with the H-2Dd gene.
When the resulting transfectant (RBIJ5pDd1) was used, the
selective elimination in theD8 mice was abrogated (Fig. 6) .
As a control, RBIr5 was transfected with the H-2Dp gene
and used in the same experiments. For this transfectant the
pattern of elimination was similar to that of untransfected
RBIr5 .
H-2 Transgene in theHost Venus H-2Deficiency in the Target.
Kinetics and Organ Distribution o,f Clearance in Tu~o Di, erent
Situations. The survival of RBIJ5 in B6 mice at different
time points was used as a control for elimination caused by
the H-2Dd transgene in the host (comparison with RB1J5
into (D8 x B6)Ft or D8 elimination caused by the H-2
deficiency of the target (comparison withRMAS into B6) .
Neither comparison revealed any significant differences at 15
min or 4 h after inoculation (Fig . 7 A-C) . However, at 12
h, a significant difference between B6 and (B6 x D8)Ft
(Fig . 7 A, Exp . 1), or between B6 and DS (Fig. 7 D, Exp.
2) in the ability to eliminate RMA was seen in the lungs .
In the same comparison, there was also a significantly better
elimination ofRMAS than o£RMA in normalB6 mice (Fig.
7, A and D) . In all cases this difference was more pronounced
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Figure 7.
￿
Time kinetics of elimination in
B6, D8 and (D8 x B6)Fl mice. The figures
show remaining radioactivity in thelungs (A
and D), liver (B andE) and spleen (C and
F) at three different timepoints after in-
oculation . The host/tumor combinations
were RMA to B6 (o
￿
ban), RMA to D8
or (D8 x B6)Fl
￿
lied ban) and H-2 de-
ficient variant RMA-S to B6 (cross hatched
ban) . A-Cand D-F represent two different
experiments. The lung differences at 12 h
between normal and transgenic B6 mice in
the ability to eliminateRMA, were in both
experiments statistically significant (p <
0.001 in A, andp< 0.001 in D) . Similarly,
the differences between RMA and RMA-S
in lung survival in B6 mice were in both
cases significant (p <0.01 in A, andp<0.001
in D) .
than the difference betweenRMA in B6 and transgenic mice.
The differences were smaller in the liver and could not be
seen in the spleen (Fig. 7 B, E, C, and F).
Discussion
Our results indicate a direct influence of a MHC trans-
gene on rapid elimination of tumor grafts mediated by NK
cells . This extends previous studies withMHC congenic mice,
where elimination within 4-36 h after inoculation of radio-
labeled cells has been shown to beT cell independent (11-13) .
Another main conclusion is that the transgene effect varied
depending on the target cell, i.e., it affected the repertoire
rather than general levels of killing. The effect of the trans-
gene could be seen against several lymphomas of H-2b back-
ground, but could not be detected against three allogeneic
lymphomas (P815, L1210, and YAC-1), nor against a com-
pletely H-2 negative lymphoma variant (A.H-2 - ) and a H-2
deficient mutant of the H-2b lymphoma RBh5 (RMAS) .
We interpret this as a consequence of efficient natural killing
of these cells in control as well as in transgenic mice, rather
than absence ofNK effects in both genotypes . The recovered
levels ofradioactivity were low and YAC-1, L1210, andRMASare known to be efficiently cleared by NK cells in B6 and
B10 mice (11, 13, 14, 28) . EfficientNK mediated elimination
of RMA-S in both (D8 x B6)Fl and B6 mice was also
demonstrated directly by the use of host treatment with
anti-NK1 .1 mAb (Fig. 5) .
Why was the elimination efficient against some cells in
normal B6 mice, while other targets were killed only in the
B6 mice carrying the H-2Dd gene? In previous studies, the
match or mismatch of H-2 between host and target has been
emphasized as an important factor contributing to rapid elimi-
nation (11, 13, 29) . There were two possible explanations
of the data in that respect : (a) Expression of a particular class
I molecules on the target (e.g., H-213d, common for P815,
L1210, and YAC-1) triggered the NK elimination in B6 as
well as D8 mice, resulting in equally efficient elimination
in both strains. (b) Complete H-2 class I match between target
and host (e.g., RBIT5 to B6) prevented elimination . Our data
support the second alternative . The differences in elimina-
tion between D8 and B6 mice seen for tumor cells of the
H-2b genotype could be abrogated by interfering with this
match, either by reducing endogenous H-2b expression in the
lymphoma cells, or by introducing the "transgene" (H-213d)
in the lymphoma cells by transfection . In the former case
efficient elimination occurred in both hosts, while in the latter
lymphoma cells survived in both hosts. Thus, theH-2 match
in the syngeneic (RBL5 to B6) or "transsyngeneic" (RBL
5pDd1 to D8) situation prevented elimination .
A recent survey of multiple host/donor combinations sup-
ports a role for self match in prevention of rapid elimination
of grafted lymphocytes in the rat (30) . However, also active
recognition of allogeneicMHC by NK cells has been postu-
lated in the rat (30, 31) . It is unlikely that the allogeneic lym-
phomas in our study were actively recognized and eliminated
in B6 mice because they expressed foreign MHC . The H-2
negative YAC-1 variant A.H-2 - does not translate its 02m
transcripts, and is therefore unable to express any class I mol-
ecules on the cell surface (21) . Yet, it was at least as efficiently
eliminated as YAC-1 in D8 and B6 mice . This showed that
expression of H-2Dd (or any class I molecules) on the cell
surface was not required for elimination . Furthermore, in-
troduction of foreign MHC genes (H-2Dd or H-2Dp) did
not result in increased elimination in B6 (Fig . 6) . Thus, we
find no evidence that allogeneic H-2 in the target cell can
trigger a response. However, it must be noted that in bone
marrow graft experiments, H-2Dd introduced as a transgene
to B6 mice resulted in aNK mediated rejection by non trans-
genic B6 mice (32) . The reasons for this differential effect
of H-213d on lymphoma and bone marrow cells are not
known . One possibility is that the transgene suppresses ex-
pression of endogenous H-2Kb,Db molecules in bone
marrow but not in lymphoma cells, a possibility that is now
being tested . Another possibility is that different subsets of
NK1.1+ cells are active in marrow and lymphoma rejection .
Recently, a CD3+, NK1.1+ cell has been shown to mediate
marrow graft rejection (33) . Our results do not distinguish
between CD3- , NK1.1+, and CD3+, NK1.1+ as respon-
sible effector cells . However, the latter are thymus dependent
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(33, 34), while the rapid elimination ofH-2 mismatched lym-
phoma cells has been demonstrated also in nude mice (11) .
The allogeneic tumors used in this study share one allele
with the D8 mice, H-2Dd , but none with B6 . However,
they did not survive better in H-213d positive D8 than in
B6 mice. We propose that the partial match with respect to
H-213d is insufficient to compensate for the lack of match
with respect to H-2Kb and Db . A prediction from this is
that H-2d cells, such as L1210, transfected with the relevant
H-2b sequences should become resistant to elimination in
both D8 and B6 mice.
A.H-2 - showed differential sensitivity to elimination by
CBA and A/Sn mice (Fig. 4), two strains with aknown differ-
ence in levels ofNK activity against YAC-1 (14) . SinceA.H-
2 - lacks MHC expression at the cell surface, it can be re-
garded as an "indicator" ofNK activity, irrespective ofmatch
or mismatch between host and targetMHC genotypes . Since
there was no difference between D8 and B6 for A.H-2 -, we
conclude that the the H-213d transgene has not altered the
general levels of NK activity in the B6 strain.
Restoration ofMHC class I expression by transfection has
been reported to protect from NK lysis in several MHC
deficient targets, even if this is not a general rule (reviewed
in reference 35) . The present study extends these findings
by two original observations : (a) The transfected gene pro-
tected from NK mediated elimination in vivo, and (b) The
recipient line did not from the start have a primary general
H-2 deficiency. Furthermore, we show that the protective
effect was specific for a class I allele that corrected the trans-
gene induced mismatch, since the control transfectant RBI,
5Dp was not accepted in D8 mice. Presence of the H-2Dd
transgene in D8 donor mice also led to protection of their
bone marrow from rejection in H-2Dd expressing B10.D2
mice (32), although it was not formally shown that the pro-
tective effect of the transgene was exerted in the grafted cell,
as in the present study. Conversely, bone marrow (reference
36, H6glund, manuscript submitted for publication) and Con
A induced T cell blasts (H6glund, P., C. Ohlen, E . Car-
bone, L . Franksson, H.-G. Ljunggren, A . Latour, B. Koller,
andK. Karre, manuscript submitted for publication) from
mice deficient in 02m/MHC class I, are recognized and
killed by NK cells from 02m expressing mice. Interestingly,
02m deficient NK cells failed to kill the 02m deficient bone
marrow and Con A blasts, further supporting the role of
the class I environment in calibrating the NK repertoire
(H6glund, P., C . Ohlen, E. Carbone, L . Franksson, H.-G.
Ljunggren, A . Latour, B . Koller, and K . Karre, manuscript
submitted for publication, C. Ohldn, manuscript in prepa-
ration) .
"Protective epitopes" have been mapped to the a-1 and
cx-2 domains in a study ofHLA transfected humanNK targets
(37), but the mechanism behind the effect is not known . It
could occur either through aMHC class I mediated/presented
negative signal to effector cells - the "effector inhibition" model
(35) - or by interference with another NK target antigen -
the "target interference" model (35) . If the target antigen
interfered with in the latter case was polymorphic andMHClinked, this model can be reconciled with the recessive Hh
antigen model (7) . A recessive target antigen has recently
been proposed for recognition ofPHA blasts by alloreactive
CD3 - , CD16+ human NK cells. Resistance to lysis was
dominantly inherited and segregated with HLA haplotype
in a family study of lymphocyte target donors (38) . If resis-
tance is controlled by an HLA class I (like) gene in thishuman
system, it may represent an analogue to the H-2Dd medi-
ated protection from NK mediated rejection ofbonemarrow
(32) and lymphoma grafts (this study) in allogeneic or trans-
genic recipients expressing H-2Dd .
The rejection of H-2b lymphomas in the D8 strain was
most pronounced in the lungs but was also observed in the
liver. The small difference in splenic clearance was surprising,
since the spleen is the standard source ofNK cells for in vitro
assays. For some previously studied tumors, the spleen was
the primary organ for in vivo clearance by NK cells (13),
while other tumors were cleared more efficiently in the lungs
as in this study (14) . The reasons for these differences are
not known but they may reside in the choice of strains or
tumor cells under study. Some tumor cells may express adhe-
sion molecules specific for capillaries of the lung or liver, while
others home primarily to the spleen. It is also possible that
tumor cells arrested in the lungs can recruit NK cells from
the circulation and the spleen, leaving fewer cells for tumor
elimination in this organ. It should also be noted that highly
active NK cells can be isolated from the liver as well as from
the lungs (39) .
The elimination ofRMA-S in B6 resembled that ofRBIr5
in D8 mice both with respect to organ distribution and ki-
netics (Fig. 7) . The main difference was in the strength of
killing, which was one order of magnitude higher for elimi-
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